Press releases | WebDisclosure

Basculer en Français

9544	Companies
188064	Keywords
119957	Articles
100451	Press releases

Home
Press releases

PRESS RELEASE

published on 05/12/2025 at 07:30, 7 months 5 days ago

Klea Holding démarre fort le deuxième trimestre 2025 avec un nouveau record en avril pour sa filiale Smart Salem
Smart Salem établit un nouveau record mensuel avec 18 497 tests en avril 2025, illustrant la croissance continue de l'entreprise. Klea Holding confirme sa stratégie de développement

Croissance Performance Smart Salem Klea Holding Record Mensuel
PRESS RELEASE

published on 05/12/2025 at 07:30, 7 months 5 days ago

Klea Holding mark strong start to Q2 2025 with new monthly record in April for its subsidiary Smart Salem
Smart Salem, a subsidiary of Klea Holding, achieves a new monthly record by conducting 18,497 tests in April 2025, displaying a 94% year-on-year growth. Growth strategy in progress

Growth Strategy Smart Salem Klea Holding Monthly Record Digitalized Medical Analysis
PRESS RELEASE

published on 05/12/2025 at 07:30, 7 months 5 days ago

Informations privilégiées / Autres communiqués
MaaT Pharma annonce des données finales prometteuses pour son essai de Phase 1b évaluant MaaT033 dans la Sclérose Latérale Amyotrophique (SLA). Résultats encourageants et implications thérapeutiques importantes

Microbiome Ecosystem Therapies MaaT Pharma Sclérose Latérale Amyotrophique Phase 1b Modulation Du Microbiote
PRESS RELEASE

published on 05/12/2025 at 07:30, 7 months 5 days ago

Information financière trimestrielle / Information financière du premier trimestre
Hausse des taux d'occupation dans les maisons de retraite en France et à l'international. Croissance organique du chiffre d'affaires de +6,2% au premier trimestre 2025, avec 1 Md€ de cessions sécurisées à fin avril

Chiffre D'affaires Croissance Organique Taux D'occupation Cessions Perspectives 2025
PRESS RELEASE

published on 05/12/2025 at 07:10, 7 months 5 days ago

Hypoport starts 2025 with strong earnings in Q1
Hypoport SE reports strong earnings in Q1/2025 with 19% revenue growth and 88% rise in EBIT. Real Estate & Mortgage Platforms drive performance

Revenue Growth Financial Performance Hypoport SE Q1 Results Real Estate & Mortgage Platforms
PRESS RELEASE

published on 05/12/2025 at 07:05, 7 months 5 days ago

Solid growth in the cloud // Pinnacle Award 2025 // Geopolitical environment leads to project delays despite strong pipeline // Forecast confirmed
All for One Group SE reports solid growth in cloud services despite geopolitical challenges causing project delays. Unaudited results show sales at EUR 257.6 million and dividend increased to EUR 1.60 per share. Forecast for 2024/25 confirmed

Cloud Services Geopolitical Challenges Forecast All For One Group SE Project Delays
PRESS RELEASE

published on 05/12/2025 at 07:00, 7 months 5 days ago

AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
AEVIS VICTORIA SA reports 17.0% revenue growth in Q1 2025, driven by Swiss Medical Network and MRH Switzerland AG. Expansion and acquisitions support momentum

Revenue Growth Acquisitions AEVIS VICTORIA SA Swiss Medical Network MRH Switzerland AG
PRESS RELEASE

published on 05/12/2025 at 07:00, 7 months 5 days ago

AEVIS VICTORIA SA – Croissance soutenue du chiffre d’affaires dans les divisions opérationnelles. Augmentation de 17.0% au 1er trimestre 2025.
AEVIS VICTORIA SA a enregistré une croissance soutenue de 17.0% de son chiffre d’affaires au 1er trimestre 2025. Swiss Medical Network et MRH Switzerland AG ont vu une augmentation organique de 3.2%

Chiffre D’affaires Croissance Soutenue AEVIS VICTORIA SA Swiss Medical Network 1er Trimestre 2025
PRESS RELEASE

published on 05/12/2025 at 07:00, 7 months 5 days ago

Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals announces approval for pivotal Phase III ENIGMA-TRS program evaluating evenamide as add-on therapy in treatment-resistant schizophrenia patients. Study results expected in Q4 2026

Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program
PRESS RELEASE

published on 05/12/2025 at 06:58, 7 months 5 days ago

ProCredit in Q1 advances on its growth and transformation strategy with good financial result
ProCredit Holding AG advances on growth and transformation strategy in Q1 with good financial result, proposes dividend of EUR 0.59 per share for FY 2024

Growth Strategy Dividend Proposal ProCredit Holding AG Q1 Financial Result

Accesswire

Published on 12/17/2025 at 15:00, 14 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 1 hour 14 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 1 hour 39 minutes ago

Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 1 hour 59 minutes ago

Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 2 hours 14 minutes ago

Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan

View all ACCESSWIRE

EQS Group

Published on 12/17/2025 at 15:04, 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/17/2025 at 15:04, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/17/2025 at 15:03, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/17/2025 at 15:03, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/17/2025 at 15:02, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The

Les Echos

Published on 12/16/2025 at 21:45, 17 hours 29 minutes ago

Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 19 hours 4 minutes ago

donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 19 hours 4 minutes ago

Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 20 hours 21 minutes ago

Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 20 hours 21 minutes ago

Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE